Log in
NASDAQ:RTTR

Ritter Pharmaceuticals SEC Filings & 10K Form

$4.04
-0.04 (-0.98 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.86
Now: $4.04
$4.25
50-Day Range
$0.45
MA: $4.59
$5.23
52-Week Range
$0.15
Now: $4.04
$1.27
Volume1.44 million shs
Average Volume14.23 million shs
Market Capitalization$186.46 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.43

SEC Filings

Ritter Pharmaceuticals (NASDAQ:RTTR) SEC Filings

DateFilerForm TypeView
10/09/2020
3:15 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
3:53 PM
Ritter Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/28/2020
1:01 PM
BROIDRICK AMY S. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
12:59 PM
BROIDRICK AMY S. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2020
7:00 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
3:22 PM
Ritter Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
8:54 PM
Ritter Pharmaceuticals (Issuer)
SEKISUI DIAGNOSTICS, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
5:16 AM
Ritter Pharmaceuticals (Filer)
Form 424B5
07/10/2020
3:40 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
1:35 PM
Ritter Pharmaceuticals (Filer)
Form 424B5
07/09/2020
5:02 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
11:32 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
8:27 PM
Ritter Pharmaceuticals (Issuer)
Ritter Ira E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:26 PM
David Richard A. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:26 PM
Poirier Michael S. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:24 PM
Abdul-Ahad Wajdi (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:23 PM
Kruger Kurt H (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:23 PM
Ritter Pharmaceuticals (Issuer)
Sinha Shishir K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:22 PM
Korenberg Matthew E (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:21 PM
Lotz Christopher L. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
2:48 PM
Ritter Pharmaceuticals (Filer)
Form 8-K/A
06/01/2020
3:46 PM
Greenblock Capital, LLC (Filed by)
Ritter Pharmaceuticals (Subject)
Form SC 13G
05/29/2020
4:17 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
4:03 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
6:12 PM
Ritter Pharmaceuticals (Issuer)
SEKISUI DIAGNOSTICS, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
5:07 PM
Abdul-Ahad Wajdi (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:05 PM
Ritter Pharmaceuticals (Issuer)
Sinha Shishir K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:04 PM
Poirier Michael S. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:03 PM
Lotz Christopher L. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
5:01 PM
Kruger Kurt H (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
4:59 PM
David Richard A. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
4:10 PM
Poirier Michael S. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:08 PM
Ritter Pharmaceuticals (Issuer)
Sinha Shishir K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:07 PM
Korenberg Matthew E (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:05 PM
Lotz Christopher L. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:03 PM
Kruger Kurt H (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
4:01 PM
David Richard A. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
2:25 PM
Abdul-Ahad Wajdi (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/27/2020
11:57 AM
Ritter Pharmaceuticals (Filer)
Form 424B5
05/20/2020
4:12 PM
Ritter Pharmaceuticals (Filer)
Form S-4MEF
05/19/2020
2:44 PM
Ritter Ira E. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
2:43 PM
Beck John W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
2:42 PM
Ritter Andrew J (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
4:12 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
4:10 PM
Ritter Pharmaceuticals (Subject)
Form 425
05/14/2020
8:50 AM
Ritter Pharmaceuticals (Filer)
Form 424B3
05/11/2020
7:03 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
7:02 AM
Ritter Pharmaceuticals (Subject)
Form 425
05/06/2020
8:22 AM
Ritter Pharmaceuticals (Subject)
Form 425
05/05/2020
5:13 AM
Ritter Pharmaceuticals (Subject)
Form 425
05/01/2020
4:31 PM
Ritter Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2020
4:30 PM
Ritter Pharmaceuticals (Subject)
Form 425
05/01/2020
4:29 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
6:35 AM
Ritter Pharmaceuticals (Subject)
Form 425
04/21/2020
5:10 AM
Ritter Pharmaceuticals (Subject)
Form 425
04/21/2020
5:06 AM
Ritter Pharmaceuticals (Subject)
Form 425
04/09/2020
11:15 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
04/09/2020
8:30 AM
Ritter Pharmaceuticals (Filer)
Form 424B3
04/06/2020
4:18 PM
Ritter Pharmaceuticals (Filer)
Form S-4/A
04/06/2020
5:15 AM
Ritter Pharmaceuticals (Filer)
Form S-4/A
03/31/2020
4:29 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
4:27 PM
Ritter Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2020
5:15 AM
Ritter Pharmaceuticals (Filer)
Form NT 10-K
03/27/2020
4:31 PM
Ritter Pharmaceuticals (Filer)
Form S-4/A
03/16/2020
4:53 PM
Doyle Noah (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:26 PM
Ritter Ira E. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
5:13 PM
Ritter Andrew J (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
7:32 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
7:30 AM
Ritter Pharmaceuticals (Subject)
Form 425
03/03/2020
5:17 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
5:15 AM
Ritter Pharmaceuticals (Subject)
Form 425
03/03/2020
5:12 AM
Ritter Pharmaceuticals (Filer)
Form 424B5
02/27/2020
8:00 PM
Doyle Noah (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
6:52 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
6:50 AM
Ritter Pharmaceuticals (Subject)
Form 425
02/14/2020
8:56 AM
Alyeska Investment Group, L.P. (Filed by)
Ritter Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2020
5:26 AM
Ritter Pharmaceuticals (Filer)
Form S-4
Registration statement under Securities Act of 1933  
01/21/2020
8:20 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
8:19 AM
Ritter Pharmaceuticals (Subject)
Form 425
01/17/2020
5:16 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
5:13 PM
Merino William M. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
5:06 PM
MAIER PAUL V (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
5:01 PM
Doyle Noah (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
8:00 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
8:58 PM
Ritter Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2019
8:25 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
8:56 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
8:52 PM
Ritter Pharmaceuticals (Filer)
Form 424B3
11/01/2019
3:15 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:15 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
4:27 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
3:30 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:00 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:12 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:45 PM
Ritter Pharmaceuticals (Filer)
Form 424B3
08/01/2019
11:20 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
08/01/2019
11:15 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
07/25/2019
8:18 AM
Ritter Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/24/2019
4:29 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
4:10 PM
Ritter Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.